Understanding GLP-1 Agonists: Key Insights for Payers By: Emily Crisano PharmD, RPh , and Jason Peterson, RPh , RPh The rapid adoption of GLP-1 treatments underscores their significance in modern therapeutic practices, making it imperative for payers, healthcare providers and consumers to stay informed about their evolving uses and market dynamics
Screen discipline might be the most underrated form of self-care right now
7 Mitochondrial metabolism does not predict poor outcomes following surgery alone
Quick Answer: Berberine is not a true GLP-1 activator in the medicinal sense
Bethanechol remains the preferred drug in suspected underactive bladder: findings from nation-wide prescription analysis
Collective efforts and initiatives like the Human Cell Atlas ( powered by single-cell technologies, will provide access to a catalogue of all cell types and their subtypes for the whole of the human body